---
title: "Bio-Works receives a third follow-up order for WorkBeads affimAb worth SEK 4.0 million"
date: "2025-02-10 18:54:14"
summary: "Bio-Works Technologies ABBio-Works has received yet another order for WorkBeads affimAb, valued at SEK 4.0 million. This is the third order from the same customer this year, further confirming the strong trust in Bio-Works' products. The latest order is intended for a new process in the customer’s operations.\"Receiving a third..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Bio-Works Technologies AB

Bio-Works has received yet another order for WorkBeads affimAb, valued at SEK 4.0 million. This is the third order from the same customer this year, further confirming the strong trust in Bio-Works' products. The latest order is intended for a new process in the customer’s operations.

"Receiving a third follow-up order from an existing customer is a clear indication of both the quality of our products and the value we bring through our collaboration. We take great pride in seeing our solutions contribute to our customers' success and look forward to continuing our strong partnership," says Lone Carlbom, CEO of Bio-Works.

This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, 10-02-2025 11:54 CET.

**About Bio-Works**

Bio-Works enables Biotech companies to achieve their goals for purification of biomolecules. We support our customers, from laboratory research to commercial production, and together we implement efficient and robust solutions for bioprocessing. Our ambition is to be a trusted and dynamic partner in an industry characterized by growth and development. Bio-Works headquarters,with R&D and manufacturing, is located in Uppsala Business Park, Uppsala, Sweden. We supply our products to a global market, through a combination of direct sales and distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Spotlight Stock Market ("BIOWKS"). For further information please contact us, www.bio-works.com.   This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.

**Contacts**

For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Lone Carlbom, CEO, e-mail: lone.carlbom@bio-works.com (lone.carlbom@bio-works.com), phone: +46(0)8-502 705 84.

https://news.cision.com/bio-works-technologies-ab/r/bio-works-receives-a-third-follow-up-order-for-workbeads-affimab-worth-sek-4-0-million%2Cc4103060

Release

[Reuters](https://www.tradingview.com/news/reuters.com,2025-02-10:newsml_Wkr41PpX1:0-bio-works-receives-a-third-follow-up-order-for-workbeads-affimab-worth-sek-4-0-million/)
